Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists
Alexander Gillis, Arisbel B. Gondin, Andrea Kliewer, et al.
Science Signaling (2020) Vol. 13, Iss. 625
Open Access | Times Cited: 315

Showing 1-25 of 315 citing articles:

Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
Damien Bertheloot, Eicke Latz, Bernardo S. Franklin
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1106-1121
Open Access | Times Cited: 1367
Sphingolipids in metabolic disease: The good, the bad, and the unknown
Christopher D. Green, Michael Maceyka, L. Ashley Cowart, et al.
Cell Metabolism (2021) Vol. 33, Iss. 7, pp. 1293-1306
Open Access | Times Cited: 190
Improving translation of animal models of addiction and relapse by reverse translation
Marco Vènniro, Matthew L. Banks, Markus Heilig, et al.
Nature reviews. Neuroscience (2020) Vol. 21, Iss. 11, pp. 625-643
Closed Access | Times Cited: 181
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 163
Molecular recognition of morphine and fentanyl by the human μ-opioid receptor
Youwen Zhuang, Yue Wang, Bingqing He, et al.
Cell (2022) Vol. 185, Iss. 23, pp. 4361-4375.e19
Open Access | Times Cited: 155
Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery
Lauren M. Slosky, Marc G. Caron, Lawrence S Barak
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 283-299
Open Access | Times Cited: 138
Insights into distinct signaling profiles of the µOR activated by diverse agonists
Qianhui Qu, Weijiao Huang, Deniz Aydin, et al.
Nature Chemical Biology (2022) Vol. 19, Iss. 4, pp. 423-430
Open Access | Times Cited: 84
Structure-based design of bitopic ligands for the µ-opioid receptor
Abdelfattah Faouzi, Haoqing Wang, Saheem A. Zaidi, et al.
Nature (2022) Vol. 613, Iss. 7945, pp. 767-774
Closed Access | Times Cited: 83
Molecular mechanism of biased signaling at the kappa opioid receptor
Amal El Daibani, Joseph M. Paggi, Kuglae Kim, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 58
β−Arrestins: Structure, Function, Physiology, and Pharmacological Perspectives
Jürgen Wess, Antwi‐Boasiako Oteng, Osvaldo Rivera‐Gonzalez, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 854-884
Open Access | Times Cited: 55
Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl
Laura C. Chambers, Benjamin D. Hallowell, Andrew R. Zullo, et al.
JAMA Network Open (2023) Vol. 6, Iss. 9, pp. e2334540-e2334540
Open Access | Times Cited: 55
Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential
Jason Wallach, Andrew B. Cao, Maggie M. Calkins, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Direct interrogation of context-dependent GPCR activity with a universal biosensor platform
Remi Janicot, Marcin Maziarz, Jong‐Chan Park, et al.
Cell (2024) Vol. 187, Iss. 6, pp. 1527-1546.e25
Open Access | Times Cited: 21
Ligand efficacy modulates conformational dynamics of the µ-opioid receptor
Jiawei Zhao, Matthias Elgeti, Evan S. O’Brien, et al.
Nature (2024) Vol. 629, Iss. 8011, pp. 474-480
Open Access | Times Cited: 21
GPCR drug discovery: new agents, targets and indications
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor
Alexander Gillis, Andrea Kliewer, Eamonn Kelly, et al.
Trends in Pharmacological Sciences (2020) Vol. 41, Iss. 12, pp. 947-959
Open Access | Times Cited: 124
Biased Opioid Ligands
Abdelfattah Faouzi, Balázs Varga, Susruta Majumdar
Molecules (2020) Vol. 25, Iss. 18, pp. 4257-4257
Open Access | Times Cited: 105
Abnormal brain cholesterol homeostasis in Alzheimer’s disease—a targeted metabolomic and transcriptomic study
Vijay R. Varma, Hatice Büşra Lüleci̇, Anup Mammen Oommen, et al.
npj Aging and Mechanisms of Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 102
Synthesis, Chemical Characterization, and μ-Opioid Receptor Activity Assessment of the Emerging Group of “Nitazene” 2-Benzylbenzimidazole Synthetic Opioids
Marthe M. Vandeputte, Katleen Van Uytfanghe, Nathan K. Layle, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 7, pp. 1241-1251
Open Access | Times Cited: 96
The anomalous pharmacology of fentanyl
Eamonn Kelly, Katy J. Sutcliffe, Damiana Cavallo, et al.
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 797-812
Closed Access | Times Cited: 93
Biased ligands at opioid receptors: Current status and future directions
Tao Che, Hemlata Dwivedi‐Agnihotri, Arun K. Shukla, et al.
Science Signaling (2021) Vol. 14, Iss. 677
Open Access | Times Cited: 87
G protein-coupled receptor-G protein interactions: a single-molecule perspective
Davide Calebiro, Zsombor Kőszegi, Yann Lanoiselée, et al.
Physiological Reviews (2020) Vol. 101, Iss. 3, pp. 857-906
Open Access | Times Cited: 82
Genome-scale metabolic network reconstruction of model animals as a platform for translational research
Hao Wang, Jonathan L. Robinson, Pınar Kocabaş, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 30
Open Access | Times Cited: 80
Macrophage regulation of angiogenesis in health and disease
Paul Martin, David Gurevich
Seminars in Cell and Developmental Biology (2021) Vol. 119, pp. 101-110
Open Access | Times Cited: 67
Understanding and countering opioid‐induced respiratory depression
Jordan T. Bateman, Sandy E. Saunders, Erica S. Levitt
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 813-828
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top